Medivir 2021 Annual Report published

STOCKHOLM, April 5, 2022 /PRNewswire/ — Medivir AB (Nasdaq Stockholm: MVIR) today announces that the Annual Report for 2021 now is available at the company’s website: www.medivir.com. 2021 started off with the licensing of birinapant to IGM Biosciences, which in November initiated a…

About the Author

has written 41292 stories on this site.

Copyright © 2010 Business and Corporate News.